GLP-1 Compound Legislation: States are the Next Battlefield w/ Sabina Hemme
Podcast:On The Pen GLP-1 News Published On: Fri Dec 19 2025 Description: Send a textPharma Influence & Why Patient Voices MatterLobbying Power: Eli Lilly, Novo Nordisk, and Government AccessWhy GLP-1 Medication Access Is at RiskIntroducing Sabina Hemi & the Mission of GLP WinnerWhy Compounded GLP-1s Matter for Real PatientsThe Federal “Safe Drugs” Bill: What It Claims vs What It DoesWhy This Bill Raises Red Flags for PatientsWhat Real Compounding Safety Reform Would Look LikeHow Compounding Pharmacies Are Actually Regulated TodayPrescription Reporting vs Patient SafetyIs This Bill About Safety or Litigation Data?Dose Flexibility, Personalized Medicine, and CompoundingFlorida SB 860: A Direct Threat to Compounded GLP-1sWhy Florida Compounding Impacts the Entire CountryWhy Obesity Medications Are Being Singled OutActive Pharmaceutical Ingredients (API): What Patients Should KnowFDA Oversight, the “Green List,” and State OverreachWhy Florida’s API & COA Requirements Don’t Add UpFDA Inspection Backlogs & Impossible Compliance StandardsBranded Drug Safety Issues vs Compounding ScrutinyCatalent, Novo Nordisk, and Manufacturing ConcernsCounterfeit Ozempic: The Overlooked Safety CrisisWhy Supply Chain Integrity Should Be the PriorityWhat Patients Can Do Right NowPetitions, Advocacy, and Making Your Voice HeardFlorida Residents: Why Local Action MattersFinal Thoughts on Access, Power, and Patient Advocacy🤝 Visit Our Sponsors!OTPLinks.com Decoding GLP-1 BookDecoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join👉 My Amazon Affiliate Store:https://www.amazon.com/shop/manonthemounjaroonthepenWATCH MORE!📺 We're Live M/W/F at 11 central: onthepen.tv 📲 Contact Me: dave@onthepen.comThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.